Radialis Inc

5 enregistrements totalisant 1,706,036.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Conseil national de recherches Canada $1,706,036 5 enregistrements

Enregistrements

Radialis Inc $988,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2024-2025
Canada

Radialis has developed a groundbreaking versatile organ-targeted PET platform with the assistance of IRAP. The system has been cleared by the FDA for the broad indication of visualizing and quantifyin...

Radialis Inc $598,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2022-2023
Canada

Radialis has developed a clinically-validated prototype of a breast PET imaging system that recently received FDA clearance. Market adoption requires that the system be able to image additional body a...

Radialis Inc $57,704.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support

Radialis Inc $40,656.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
EF 2020-2021
Canada

The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.

Radialis Inc $21,676.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.